Skip to main content
Caplight Logo









Anyo Labs

Anyo Labs

Private
GothenburgHealthcare & Life Scienceshttps://anyolabs.com/

Last Round

Grant

May 1, 2024

Total Funding Raised

$135,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Anyo Labs is a healthcare technology company that provides an AI-driven drug discovery platform to accelerate the identification and optimization of small-molecule drug candidates.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryai drug discoverycomputational chemistrygenerative molecular designadmet property predictionadmetmolecular modelingin silico drug discoverysmall-molecule designcomputational biologylead optimizationbiotech aipharma r&ddrug engineeringprotein interaction network

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anyo Labs Comparables

Compare Anyo Labs with similar companies based on industry and business-model similarity.

Anyo Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cortex Discovery
89%
Iktos
86%
Optibrium
79%

Anyo Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2024
AcceleratorDec 14, 2023
SeedApr 21, 2023

Key People

Founding team and executive leadership

Marek Szczygiel

Chief Executive Officer

Executive Team

Anyo Labs Investors

Notable investors and investment history

Anyo Labs investors
InvestorRounds
VinnovaGrant
Sahlgrenska Science ParkAccelerator
Chalmers VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • May 3, 2025

    Monthly visitors increased 318% MoM.

Anyo Labs Filings

Explore SEC and related filing metadata, where available.

Anyo Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anyo Labs's valuation, stock price, and market status.

Is Anyo Labs a public or private company?

Anyo Labs is a private company.

What is the current stock price of Anyo Labs?

Anyo Labs is a private company with no public stock price. Caplight tracks Anyo Labs's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Anyo Labs worth (valuation)?

Valuation information for Anyo Labs is not publicly available.

Can I buy Anyo Labs stock?

Anyo Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anyo Labs's last funding round?

Anyo Labs's most recent funding round was Grant on May 1, 2024.

Who are the main investors in Anyo Labs?

Key investors in Anyo Labs include Chalmers Ventures.

Will Anyo Labs IPO soon?

No public IPO plans have been announced for Anyo Labs.

How can I track Anyo Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anyo Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGothenburg
Employee Range8
Year Founded2022
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?